Table 4.
Per subject* | |||
---|---|---|---|
BTX** n=28 | SNM** n=73 | p value | |
Antibiotics for UTI (any) | 11 (39.3) | 27 (37.0) | 0.83 |
Bladder instillations | 0 (0) | 0 (0) | - |
Continued from baseline | 2 (7.1) | 8 (11.0) | 0.72 |
Hospitalizations | 1 (3.6) | 2 (2.7) | 0.83 |
Outpatient visits [median (range)] | 0 (0–3) | 0 (0–5) | 0.22 |
Provider phone calls [median (range)] | 0 (0–10) | 0 (0–14) | 0.99 |
**Results reported as n (%) unless otherwise noted | |||
Among total treated UTI | |||
BTX* n=20 | SNM* n=47 | p value | |
Bladder instillations | - | - | - |
Unknown duration | 7 (35.0) | 3 (6.4) | 0.01 |
Outpatient visits | 0.45 (0.51) | 0.79 (0.55) | 0.14 |
Provider phone calls | 1.25 (1.77) | 1.38 (1.50) | 0.88 |
Abbreviations: UTI (urinary tract infection); BTX (intradetrusor onabotulinumtoxinA); SNM (sacral neuromodulation); IV (intravenous) |